Moringa Moringa oleifera Lam.
Also called: drumstick tree, horseradish tree, malunggay, Moringa pterygosperma (illegitimate name for this species)
Moringa is a deciduous tree from the Indian subcontinent, now cultivated in tropical and subtropical climates worldwide. Its leaves, seeds, flowers and roots are eaten as food and used in traditional medicine; supplements mostly use leaf powder or extract.
- Category
- Botanical
- Part used
- Leaf (also seed, flower, root and bark in traditional use)
- Strongest evidence
- B Some positive trials
- Native range
- Native from northeastern Pakistan to northwestern India (POWO: "NE. Pakistan to NW. India")
- Reviewed
- 2026-10-29
Class 1 Well studied in people. A 2025 meta-analysis (Nutrients) pooled 9 RCTs (12 study arms; 649 adults) of moringa supplementation for cardiometabolic outcomes; one of the 9 used a polyherbal formulation containing moringa leaf extract, so 8 tested moringa alone. [3]
Fact-checked 2026-10-29 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BPregnancy and infants1 topic
CHeart and blood vessels2 topics
CSeveral areas, whole body or blood1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood sugar, blood lipids and body weight in adults | C | A 2025 meta-analysis of nine randomized trials (649 participants) found no significant effect on most cardiometabolic outcomes; GRADE certainty was very low for all outcomes. [3] |
| Blood pressure in adults | C | The 2025 Crișan meta-analysis of nine randomized trials found a modest reduction in diastolic blood pressure that was not robust in sensitivity analyses. [3] |
| Breast-milk supply | B | LactMed cites a meta-analysis (14 studies, 865 subjects) indicating increased serum prolactin and milk volume; other pooled analyses combined small studies, some with methodologic problems. Long-term benefit to infants is not well studied. [2] |
| Overall clinical evidence | C | LiverTox states that small, short trials suggested lower fasting blood sugar, but effects were modest and of unclear clinical benefit; none of moringa's purported activities has been convincingly demonstrated in humans. [1] |
Main constituents: Polyphenols, phenolic acids, flavonoids, glycolates and alkaloids; candidate active compounds named include kaempferol, myricetin, niazirin and moringin, but none has been definitely shown to be responsible [1]; Leaves contain vitamins, minerals and essential amino acids as well as several glycosides [2]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- LiverTox describes products of 100 mg to 1 gram, with labeled daily amounts from 500 mg to 5 or 6 grams (a description of products, not a recommendation). [1]
- Lactation studies included 3.2 grams daily of leaf powder or extract, and 500 mg of leaf powder or extract twice daily. [2]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Score DABCDEA: well known causeE: unlikely cause
LiverTox likelihood score D: possible rare cause of clinically apparent liver injury. Not linked to serum enzyme elevations in trials …
Details and sources - Pregnancy and breastfeedingLactation: LactMed reports no serious short-term adverse effects in nursing mothers or their breastfed infants in studies …
1 statement in the profile.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications4 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Liver: LiverTox likelihood score D (possible rare cause of clinically apparent liver injury). Moringa was well tolerated in trials without changes in liver tests; one case of acute hepatitis attributed to it has been published. [1]
- No serious short-term adverse effects were found in nursing mothers who took moringa leaves or in their breastfed infants. Moringa may stimulate blood clotting, so LactMed advises caution in anyone at high risk for blood clots. [2]
Regulatory status
- US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [5]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Polyphenols, phenolic acids and flavonoids; LiverTox names kaempferol, myricetin, niazirin and moringin as candidate actives, none definitely shown Polyphenols, phenolic acids and flavonoids [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 4 entries naming moringa (earliest NDI 193 submitted 2003-01-21, listed as Moringa pterygosperma within a multi-ingredient product; most recent NDI 1069 submitted 2018-03-16). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of moringa (Moringa oleifera) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]
Liver (NIH LiverTox)
- LiverTox likelihood score D: possible rare cause of clinically apparent liver injury. Not linked to serum enzyme elevations in trials; a single case of acute anicteric hepatitis from Brazil has been published (chapter updated 2024-07-15). [P1]
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of the dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P4]
Supply and conservation
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- Lactation: LactMed reports no serious short-term adverse effects in nursing mothers or their breastfed infants in studies; because moringa may stimulate blood clotting, caution is advisable in anyone at high risk for blood clots. [P6]
Sources for this profile
- NIH LiverTox (NIDDK). Moringa (Last Update: 2024-07-15), 2024-07-15. ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (list last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
- eCFR. 21 CFR 111.75 (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- GBIF species API: IUCN Red List category for Moringa oleifera Lam., 2026-10-29. api.gbif.org
- NIH NICHD. Drugs and Lactation Database (LactMed). Moringa (revised 2026-07-15), 2026-07-15. ncbi.nlm.nih.gov
Sources
- NIH LiverTox (NIDDK). Moringa (Last Update: 2024-07-15), 2024-07-15. ncbi.nlm.nih.gov
- NIH NICHD. Drugs and Lactation Database (LactMed). Moringa (revised 2026-07-15), 2026-07-15. ncbi.nlm.nih.gov
- Crișan D, et al. Effects of Moringa oleifera Lam. supplementation on cardiometabolic outcomes: a meta-analysis of randomized controlled trials with GRADE assessment. Nutrients 2025;17(22):3501 (PMID 41305552), 2025-11-07. pubmed.ncbi.nlm.nih.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew. Moringa oleifera Lam. (accessed 2026-10-29); Moringa pterygosperma Gaertn. is an illegitimate name pointing to M. oleifera in WCVP (GBIF dataset f382f0ce-323a-4091-bb9f-add557f3a9a2, 2026-06-04). powo.science.kew.org
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.